Overall rank by patents
#28,767
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 17 technology areas, active 2018–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B30B (PRESSES IN GENERAL).
The verdict
Fibro holds 9 US patents across 17 technology areas, rank #28,767 of 50,000 tracked assignees.
Fibro Gmbh has been granted 9 US utility patents between 2018 and 2023, placing Fibro Gmbh at rank #28,767 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.8 claims per patent with primary concentration in B30B (PRESSES IN GENERAL). As a Foreign Corporation, Fibro Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Fibro sits between Fast & Fluid Management B.v. (9 patents, rank #28,763) and Fingram Co., Ltd (9 patents, rank #28,771) - the closest US assignees by grant volume. The composite Innovation Score of 42.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 1 in the 2015–2019 window, a +700% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fibro Gmbh's 14.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fibro Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Fast & Fluid Management B.V.
9 patents
Feasible, Inc.
9 patents
Feel the World, Inc.
9 patents
Fenton Mobility Products, Inc.
9 patents
Fifth Electronics Research Institute of Ministry of Industry and Information Technology
9 patents
Filtration Technology Corporation
9 patents
Finalmouse LLC
9 patents
Fingram Co., Ltd
9 patents
Fibro GmbH
9 patents
What this shows Fibro holds 9 patents at rank #28,767, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,767 in granted patent volume.
Other assignees with the most granted patents in Fibro's primary technology class.
Fibro's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 30% higher than 70% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 11.1% |
| 2021 | 3 | 33.3% |
| 2022 | 3 | 33.3% |
| 2023 | 2 | 22.2% |
Top 15 of 17 technology areas
Overall rank by patents
#28,767
Across all tracked assignees
42.5 out of 100
How to use this portfolio
Fibro's 9 grants land it in the top 30% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.